Search - tctmd.com

Displaying 261 - 280 of 573

Sort: Relevancy | Date

Presentation TVT 2022

Transcatheter Chordal Replacement: Technology Concepts and Program Updates

Presenter: Azeem Latib

June 08, 2022

Presentation TVT 2022

You’re All Wrong: A Toolbox Approach Is the Future of Transcatheter Mitral Intervention!

Presenter: Vinod H. Thourani

June 08, 2022

Presentation TVT 2022

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Presenter: Brian Whisenant

June 08, 2022

Presentation TVT 2022

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Presenter: D. Scott Lim

June 08, 2022

Presentation TVT 2022

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

Presenter: Scott Lim

June 08, 2022

Presentation TVT 2022

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Presenter: Paul Sorajja

June 08, 2022

Presentation TVT 2022

Innovation in TMVr: Lessons Learned From the Surgeons

Presenter: Thomas Modine

June 08, 2022

Presentation Miami Valves 2022

Transcatheter Mitral Valve Indirect Annuloplasty Repair for Functional Mitral Regurgitation

Presenter: Adithya Mathews

February 04, 2022

Presentation TCT 2021

Limitations of TEER and Justification for Additional Transcatheter Repair Concepts

Presenter: Georg Nickenig

November 05, 2021

Presentation TCT 2021

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Presenter: Ori Ben-Yehuda

November 05, 2021

Presentation TCT 2021

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

Presenter: Joanna Chikwe

November 05, 2021

Presentation TCT 2021

Pro: TEER Is the Optimal Therapy TODAY!

Presenter: Saibal Kar

November 05, 2021

Presentation TCT 2021

New Insights From COAPT

Presenter: Gregg Stone

November 05, 2021

Presentation TCT 2021

Emerging Data From the TVT and STS Mitral Registries

Presenter: Paul Sorajja

November 05, 2021

Presentation TCT 2021

What’s New in the 2020 Valvular Heart Disease Guidelines for Primary and Secondary MR?

Presenter: Robert Bonow

November 05, 2021

Presentation TCT 2021

TCT 103: Safety and Effectiveness of Transcatheter Edge-to-Edge Repair With MitraClip™ in Atrial Functional MR: An Analysis of the Global EXPAND Study

Presenter: Nishtha Sodhi

November 05, 2021

Presentation TCT 2021

Transseptal Transcatheter Mitral Valve Chordal Repair Using the CardioMech Valve Repair System: Early First in Human Experience

Presenter: Michael Joseph Rinaldi

November 04, 2021

Presentation TCT 2021

TCT 582: Percutaneous Transcatheter Mitral Valve Repair In Patient With Dextrocardia And Cardiogenic Shock

Presenter: Arvind Reddy Devanabanda

November 04, 2021

Presentation TVT 2021

Impact of Timing of Surgery on Outcomes of Mitral Valve Surgery After Edge-to-Edge Transcatheter Mitral Repair: Results From The CUTTING-EDGE Registry

Presenter: Gilbert Tang

July 20, 2021

Presentation TCT 2020

TCT ID 5: Six-Month and One-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study

Presenter: Robert Smith

October 15, 2020

Advertisement

Transcatheter Chordal Replacement: Technology Concepts and Program Updates

You’re All Wrong: A Toolbox Approach Is the Future of Transcatheter Mitral Intervention!

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Innovation in TMVr: Lessons Learned From the Surgeons

Transcatheter Mitral Valve Indirect Annuloplasty Repair for Functional Mitral Regurgitation

Limitations of TEER and Justification for Additional Transcatheter Repair Concepts

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

Pro: TEER Is the Optimal Therapy TODAY!

New Insights From COAPT

Emerging Data From the TVT and STS Mitral Registries

What’s New in the 2020 Valvular Heart Disease Guidelines for Primary and Secondary MR?

TCT 103: Safety and Effectiveness of Transcatheter Edge-to-Edge Repair With MitraClip™ in Atrial Functional MR: An Analysis of the Global EXPAND Study

Transseptal Transcatheter Mitral Valve Chordal Repair Using the CardioMech Valve Repair System: Early First in Human Experience

TCT 582: Percutaneous Transcatheter Mitral Valve Repair In Patient With Dextrocardia And Cardiogenic Shock

Impact of Timing of Surgery on Outcomes of Mitral Valve Surgery After Edge-to-Edge Transcatheter Mitral Repair: Results From The CUTTING-EDGE Registry

TCT ID 5: Six-Month and One-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content